Boenning & Scattergood’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-1,060
Closed -$214K – 363
2020
Q4
$214K Sell
1,060
-525
-33% -$109K 0.05% 318
2020
Q3
$333K Buy
1,585
+10
+0.6% +$2.23K 0.08% 237
2020
Q2
$346K Buy
1,575
+16
+1% +$3.2K 0.09% 221
2020
Q1
$270K Buy
1,559
+234
+18% +$38.7K 0.09% 214
2019
Q4
$203K Sell
1,325
-200
-13% -$29.9K 0.05% 289
2019
Q3
$232K Sell
1,525
-75
-5% -$11.9K 0.07% 248
2019
Q2
$245K Sell
1,600
-483
-23% -$73.8K 0.07% 246
2019
Q1
$334K Hold
2,083
– – 0.1% 214
2018
Q4
$321K Hold
2,083
– – 0.11% 204
2018
Q3
$313K Buy
2,083
+23
+1% +$3.27K 0.1% 209
2018
Q2
$279K Buy
+2,060
New +$254K 0.09% 230

Other funds holding CLX

Boenning & Scattergood's CLX Position: Q1 2021 in Review

Boenning & Scattergood sold out of Clorox (CLX) in Q1 2021, closing a stake of 1,060 shares — an estimated $214K sold.

Boenning & Scattergood first reported a position in CLX in Q2 2018 and held it in 11 quarters. The position peaked at $346K in Q2 2020. 1,207 funds tracked by Wall St. Rank hold CLX as of Q1 2021.

  • Boenning & Scattergood reported no remaining Clorox position as of Q1 2021 after selling out during the quarter.
  • Boenning & Scattergood sold 1,060 Clorox shares in Q1 2021, an estimated $214K.
  • Boenning & Scattergood first reported a position in Clorox in Q2 2018 and held it in 11 quarters.
  • Boenning & Scattergood's Clorox position peaked at $346K in Q2 2020.
  • 1,207 funds tracked by Wall St. Rank held Clorox as of Q1 2021.

Based on Boenning & Scattergood's 13F filing for Q1 2021, filed 22 Apr 2021.